Adial Pharmaceuticals Inc <ADIL.O>: Alliance Global Partners initiates coverage with buy rating; price target $11
ADIL•Related News
Evercore hires Citi veteran Dylan Tornay as senior managing director in equity capital markets
EVR•
Strive reports 74,417,438 Class A shares and 9,792,535 Class B shares outstanding as of July 31, 2026
ASST•
Taysha Gene Therapies signs commercial supply deal with Catalent for TSHA-102 Rett syndrome therapy
TSHA•
BorgWarner wins extension of high-voltage inverter programs with European OEM
BWA•
American Family To Acquire Bowhead Specialty In $1.2 Billion Transaction
BOW•